awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28540521-BC32A065-435E-4830-A125-4DA9F810D4A2
Q28540521-BC32A065-435E-4830-A125-4DA9F810D4A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28540521-BC32A065-435E-4830-A125-4DA9F810D4A2
The study of a novel sorafenib derivative HLC-080 as an antitumor agent
P2860
Q28540521-BC32A065-435E-4830-A125-4DA9F810D4A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28540521-BC32A065-435E-4830-A125-4DA9F810D4A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b2ab174e023dba83ed1d071f74808b5e6215dcee
P2860
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.